GSK_Annual_Report_2021

Annual Report 2020-21 55 Central level. He worked as Secretary to the Department of Finance and then Department of Energy of Andhra Pradesh. He was a Deputy Secretary/Director in the Department of Economic Affairs, Ministry of Finance and served as Advisor to India’s Executive Director to the International Board for Reconstruction and Development, Washington. Mr. Bhide then served as Additional Secretary/Special Secretary in the Ministry of Home Affairs of the Government before being appointed as Secretary in the Department of Disinvestment with the Ministry of Finance. Mr. Bhide retired as Secretary, Department of Revenue, Ministry of Finance in January 2010, a position which he held from June 2007. He is a member of the Audit Committee, Risk Management Committee and Stakeholders Relationship Committee. List of Directorship, excluding directorship held in Private Limited Companies, Foreign Companies and Section 8 Companies. Sr. No. Directorship in listed / public entities Category of Directorship Expertise in Specific Functional Areas 1 Borosil Renewables Limited Independent Director Finance, Administration and Taxation 2 L&T Finance Holdings Limited Independent Director 3 Nocil Limited Independent Director 4 L&T Housing Finance Limited Independent Director 5 L&T Finance Limited Independent Director 6 Trl Krosaki Refractories Limited Independent Director Ms. Puja Thakur – Whole-time Director & Chief Financial Officer (Din : 07971789) Ms. Puja Thakur, age 45 years, is a Chartered Accountant and joined GSK in February 2004 from PwC. She has done various roles and has all-round experience of managing an integrated business between Commercial and Supply Chain both in India and in international markets. Prior to joining the Company, she was Finance Director for GSK Consumer, MEA Region. She was appointed with effect from 1 January 2018 and is a Director in Biddle Sawyer Limited. She has expertise in the fields of Finance & Treasury. She does not hold any shares in the Company and is also not related to any Director of the Company. Mr. Subesh Williams – Non-Executive Director (Din : 07786724) Mr. Subesh Williams, age 58 years, is a Chartered Accountant and Senior Vice President, Global Corporate Development at GSK plc, a role he was appointed to in September 2013. In his current role, Subesh is responsible for M&A and Business Development across GSK’s commercial businesses and has been involved in executing a number of transactions, including the creation of ViiV Healthcare (a HIV JV with Pfizer and Shionogi) and the 3-part deal with Novartis which involved the acquisition of Novartis’ vaccines business, the creation of a JV in Consumer Healthcare and the sale of GSK’s oncology business. In 2016, Subesh was appointed to the Board of Galvani Bioelectronics, a joint venture between GSK and Verily (a subsidiary of Alphabet). From 2009-2013, Subesh was Chief Financial Officer of ViiV Healthcare, with responsibility for Finance, Business Development, IT and Supply. Subesh joined GSK in 1994 and has held roles of increasing responsibility in Finance and Corporate Development. Prior to joining GSK, he was a Manager at PwC. He was appointed with effect from 7 April 2017. He has expertise in the fields of Finance, Business development and Mergers & Acquisitions. He does not hold any shares in the Company and is also not related to any Directors of the Company. Mr. Sridhar Venkatesh - Managing Director (Din : 07263117) Mr. Sridhar Venkatesh is a senior business leader with more than 24 years of diverse experience in pharmaceuticals and healthcare. He joined GSK in 2011 as Head of Commercial, Established Products, Branded Generics, &